Skip to content

Evofill Duo Regular Kit

by DiaDent Group International

Evofill Duo Regular Kit (4005-1001) is an endodontic obturation system (FDA Class I; FDA product code EKR, Plugger, Root Canal, Endodontic) made by DiaDent Group International, listed in FDA GUDID since 26 May 2020 (UDI-DI 08806383552332), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number08806383552332 UDI-DI Date26 May 2020ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
EvoFill Duo(Gutta percha obturation System) is an electrically powered dental device used for heating Gutta percha and placing the softened material in prepared root canals of teeth during root canal therapy.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Evofill Duo
Generic name
Endodontic obturation system
Model / Ref / Catalog
EVOFILL DUO REGULAR KIT, 4005-1001
Primary DI / UDI-DI
08806383552332
FDA product code
EKR
GMDN term
Endodontic obturation system
Device class
Class I
Regulation number
872.4565
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Endodontic obturation system.

Other devices from DiaDent Group International

See all devices from DiaDent Group International →

Properties

  • Prescription use
  • Premarket exempt
Other properties (13, all answered No)